Back to GILD
Candriam S.C.A. GILD Position History
Gilead Sciences, Inc. • Healthcare
Quarters held
6
Latest value
$185.8M
Q3 2026
Peak value
$232.8M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $179.9M |
| Q4 2025 | $225.1M |
| Q4 2025 | $224.9M |
| Q1 2026 | $232.8M |
| Q2 2026 | $150.4M |
| Q3 2026 | $185.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $185.8M | 1.24M | — | — |
| Q2 2026 | $150.4M | 1.19M | — | — |
| Q1 2026 | $232.8M | 1.67M | — | — |
| Q4 2025 | $224.9M | 1.83M | — | — |
| Q4 2025 | $225.1M | 1.83M | — | — |
| Q3 2025 | $179.9M | 1.62M | — | — |
Other funds holding GILD
$13.3B
$12.5B
$12.5B
$11.9B
$8.3B
$7.7B
$7.7B
$7.4B